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ABSTRACT 
Objectives: The main aim of this study was to construct reference ranges of the 
maternal central hemodynamic parameters during pregnancy. The second aim was 
to determine the maternal and pregnancy characteristics, which influence these 
hemodynamic parameters. 
Methods: This was a prospective cohort study of low-risk pregnant women attending 
for routine antenatal care at St George’s Hospital, London. The exclusion criteria 
included any medical disorder present at the time of study recruitment, or 
development of hypertension or intrauterine fetal growth restriction following study 
recruitment. Stroke volume (SV), cardiac output (CO) and systemic vascular 
resistance (SVR) were obtained using non-invasive cardiac output monitoring 
(USCOM-1A®). USCOM-1A® utilises a non-imaging probe in the suprasternal notch 
to obtain velocity-time integrals of transaortic blood flow at the left ventricular outflow 
tract. Once the distribution of the data had been determined with respect to the 
gestational age (GA), maternal characteristics were added to the model to test 
whether they provided a significant improvement in the prediction of the median 
value. 
Results: The analysis included 627 singleton pregnancies. The estimated median 
CO was constant for a maternal age above 32 years, but was around 0.5 L/min 
higher for women aged 25 or younger (p<0.001). Maternal weight (p<0.001) and 
height (p<0.001) affected CO and there was a significant interaction (p=0.002). In 
women with a height less than 1.60m, there was no association between median CO 
and weight. In those with a height exceeding 1.60m, an increase in weight was 
associated with an increase in CO. SV was primarily associated with height 
(p<0.001), although some positive association with weight (p<0.001) can also be 
observed within the normal body mass index range. Greater height (p<0.001) was 
associated with lower median values of SVR with an estimated difference of around 
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120 dynes·sec·cm5 between 1.60m and 1.80m. Advancing maternal age was 
associated with higher median SVR with an estimated difference of around 50 
dynes·sec·cm5 between 25 and 35 years. Smokers had a lower SVR of 73.5 (95% 
CI, 8.6 – 138.4) dynes·sec·cm5.  
Conclusion: Maternal hemodynamics are significantly influenced by maternal age, 
height and weight. We provide USCOM-1A®-specific reference ranges and calculator 
for SV, CO and SVR in uncomplicated pregnancies that correct for maternal age, 
height and weight. This will enable clinical application and comparison in both 
uncomplicated and pathological pregnancies.  
 
 
INTRODUCTION 
Non-invasive hemodynamic monitors have been used in critically ill and high-risk 
surgical patients. However, their use in an obstetric population is scarce (1-3). Given 
their non-invasive nature and lack of ionising radiation, they have an obvious 
advantage over their invasive counterparts. The invasive nature of thermodilution 
techniques utilising a pulmonary artery catheter, as well as the associated risks of 
vascular injury, infection and cardiac arrhythmias (4), render invasive monitoring in 
pregnancy an almost obsolete practice, reserved only for critical cases. There is a 
need for non-invasive hemodynamic monitoring in pregnant women, both for 
research and clinical purposes. 
A number of non-invasive cardiac output (CO) devices are commercially available. 
The device used in this study was USCOM-1A® (ultrasound cardiac output monitor, 
USCOM Ltd, NSW, Australia). Several validation studies of USCOM-1A® have been 
published in the non-obstetric (5-7) and obstetric (8) populations. Our group 
conducted a cross comparison study and reported good agreement (mean 
percentage difference <30%) between USCOM-1A® and two-dimensional 
transthoracic echocardiography in advanced pregnancy (9). In order to enable 
clinical application and further research using this methodology, it is imperative that 
we have device-specific reference ranges for an obstetric population. Furthermore, 
there is a need to investigate whether maternal central hemodynamic variables, such 
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as the stroke volume (SV), cardiac output (CO) and systemic vascular resistance 
(SVR), are influenced by the maternal characteristics such as age, height and 
weight.  
The main aim of this study was to construct reference ranges of the maternal central 
hemodynamic parameters during pregnancy. The second aim was to determine the 
maternal and pregnancy characteristics, which influence these hemodynamic 
parameters. 
 
 
 
 
METHODS  
This was a prospective cohort study in low-risk pregnant women attending a tertiary 
referral hospital between September 2012 and May 2016. The inclusion criteria were 
uncomplicated singleton pregnancies attending antenatal care at St George’s 
Hospital, London. The exclusion criteria included any medical disorder present at the 
time of study recruitment, or development of hypertension or intrauterine fetal growth 
restriction following study recruitment. Pregnancies complicated by major fetal 
anomalies, aneuploidy, intrauterine fetal demise or those undergoing termination of 
the pregnancy were excluded.  
Written consent was obtained from all study participants and local research ethics 
committee approval (12/LO/0810) was obtained prior to data collection. All women 
were examined by their midwives or obstetricians and both maternal and fetal 
wellbeing were confirmed prior to hemodynamic assessment. The gestational age 
(GA) was calculated from the crown–rump length measurement at 11–13 weeks or 
the head circumference if the first ultrasound scan was performed after 14 weeks’ 
gestation. 
Maternal history and characteristics  
Women who agreed to participate were invited to complete a questionnaire stating 
their age, ethnic origin (Caucasian, Afrocaribbean, South Asian, East Asian, 
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Mixed/Other), method of conception (spontaneous, assisted), smoking during 
pregnancy (yes/no), history of chronic hypertension (yes/no), medication history and 
a medical / obstetric history. The history and questionnaire were then reviewed by 
the study investigators to verify eligibility, and maternal height and weight were 
obtained (and examination body mass index (BMI) subsequently calculated). 
Maternal weight and BMI at pregnancy booking were also recorded.  
Haemodynamic Assessment 
USCOM-1A® measurements were performed under standardised conditions for the 
entire cohort. The study subjects had one single hemodynamic assessment  
performed during study recruitment.  Measurements were obtained with the patient 
in a semi-recumbent position. USCOM-1A® employs continuous wave Doppler, with 
a non-imaging probe in the suprasternal notch to obtain velocity time integrals (VTI) 
of transaortic blood flow at the left ventricular outflow tract. Using an anthropometric 
algorithm, which correlates the outflow tract diameter with the patient’s given height 
(10), USCOM-1A® uses the VTIs to compute the hemodynamic parameters.  The 
three variables of interest in this study are SV, CO and SVR.  
Statistical Analysis 
Models were fitted using the gamlss package (11) for R (R Foundation, Vienna, 
Austria). Improvements in model fit were evaluated using the generalised likelihood 
ratio test, with statistical significance at P<0.05. For each hemodynamic variable, a 
normal distribution with mean conditional on GA was considered first. The 
relationship of the mean with GA was flexibly modelled using a natural cubic spline 
(NCS) basis with boundary knots at the 10th and 90th centiles (87.6 and 266 days, 
respectively), and internal knots at the 30th, 50th and 70th centiles (152, 210 and 252 
days, respectively). The standard deviation was then also allowed to vary with GA, 
with the same boundary knots but with an internal knot at only the 50th centile. The 
model was then extended in each case to allow for a skewed distribution using the 
Box–Cox, Cole and Green (BCCG) distribution, and then to also adjust for the 
kurtosis (or ‘tailedness’) of the data using the Box–Cox power exponential 
distribution (BCPE) (12). For the BCCG and BCPE distributions, the median and 
scale parameter were modelled as smooth functions of GA using NCS as were the 
mean and standard deviation for the normal distribution, respectively, and the 
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skewness and kurtosis parameters were estimated as constants. Plots of 
standardized residuals were checked. 
Once the distribution of the data had been determined with respect to the GA, patient 
characteristics that might plausibly be associated with the hemodynamic variables 
were added to the model to test whether they provided a significant improvement in 
the prediction of the mean/median value. Maternal booking weight and height were 
added to the models first, each using a cubic spline basis with boundary knots at the 
10th and 90th centiles and internal knots at the 50th centiles (59.18, 74 and 96.58 
kg, and 1.56, 1.64 and 1.73 m, respectively), and an interaction term (centred at the 
medians) was then added for weight and height. A constant effect of smoking during 
pregnancy was then tested, followed by the addition of maternal age using a NCS 
basis with boundary knots at the 10th and 90th centiles and an internal knot at the 
50th centile (24, 32 and 38 years, respectively). Finally, the effects of having 
conceived using assisted reproduction, being nulliparous and ethnicity (groupings: 
Caucasian, Afrocaribbean, South Asian, East Asian, Mixed/Other) were tested. 
 
 
RESULTS 
Maternal hemodynamic measurements were performed in 758 pregnancies. A total 
of 131 cases were excluded (maternal or fetal complications or recruited to the study 
either before 10 weeks or after 40 weeks of gestation). Final analysis included 627 
single measurements. Maternal baseline characteristics and pregnancy outcome 
data are summarised in Table 1.  
 
Reference ranges  
The USCOM-1A®- specific reference ranges, displaying the 5th, 50th and 95th centiles 
for the SV, CO and SVR are shown in Figures 1-3. The normal distribution was 
adequate to model SV, but the BCPE distribution provided an improvement in model 
fit for CO and SVR. Increasing median values of CO and SV were observed from 10 
weeks until around 31 and 21 weeks respectively, with a subsequent decrease until 
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term for each variable. These changes were mirrored by a reduction in the median 
value of SVR from 10 weeks until around 32 weeks, followed by an increase towards 
term.  
 
Associations with maternal characteristics   
Cardiac Output  
Maternal weight (p<0.001) and height (p<0.001) influenced the CO values and there 
was a significant interaction (p=0.002) (Figure 4). In women with a maternal height 
less than 1.60m, there was no association between median CO and maternal weight, 
but in those with a maternal height exceeding 1.60m, an increase in weight was 
associated with an increase in CO. Maternal age was also significantly associated 
with the median CO (p<0.001). The estimated median CO was constant above the 
age of 32 years, but was around 0.5 L/min higher for women aged 25 or younger 
(Figure 5). Smoking was not a statistically significant predictor once age was added 
to the model, and so this was dropped from the model for analysis (p=0.07). No 
further significant improvements in model fit were gained by the addition of mode of 
conception (p=0.11), parity (p=0.14) or ethnicity (p=0.13).  
 
Stroke Volume 
Significant improvements in model fit were achieved by the addition of maternal 
weight (p<0.001), height (p<0.001) and their interaction (p=0.035). However, no 
further improvement to model fit was provided by smoking (p=0.12), maternal age 
(p=0.999), mode of conception (p=0.25), parity (p=0.43) or ethnicity (p=0.19). SV 
was primarily associated with maternal height, although some positive association 
with weight could also be observed within the normal BMI range (Figure 6). 
 
Systemic Vascular Resistance  
Improvements in model fit were achieved by the addition of maternal height 
(p<0.001), but not maternal weight (p=0.63). In addition to height, smoking (p=0.011) 
and maternal age (p=0.018) led to further improvements in the model fit, but mode of 
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conception (p=0.75), parity (p=0.07) and ethnicity (p=0.14) did not. Greater maternal 
height was associated with lower median values of SVR with an estimated difference 
of around 120 dynes·sec·cm5 between 1.60m and 1.80m (Figure 7). Advancing 
maternal age was associated with higher median SVR with an estimated difference 
of around 50 dynes·sec·cm5 between 25 and 35 years (Figure 8). Smokers had a 
lower SVR of 73.5 dynes·sec·cm5 (95% CI; 8.6 dynes·sec·cm5-138.4 
dynes·sec·cm5).  
A spreadsheet has been provided (Supplementary file S1; supplementary online 
material) to calculate centile positions of USCOM-1A® measurements dependant on 
either GA alone or on all significant predictors for each variable. 
 
DISCUSSION 
Summary of study findings 
This study provides reference ranges for SV, CO and SVR obtained using USCOM-
1A® in uncomplicated, singleton pregnancies. We report a significant effect of 
maternal age, weight and height on CO, of maternal weight and height on SV, and of 
maternal age, height and smoking status on SVR.   
 
Comparison with the existing literature 
This is the largest study of maternal hemodynamics in a low-risk obstetric population 
using USCOM-1A®. Kager et al (13) reported on the CO estimates of 172 patients 
across all trimesters of pregnancy, obtained using USCOM-1A®. There are currently 
no published device-specific reference ranges for USCOM-1A® in a large cohort 
consisting of uncomplicated pregnancies. There are no reported studies of this scale 
which investigate the effects of various maternal characteristics on central 
hemodynamic variables in an obstetric cohort.  
 
Clinical and research implications 
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Prior to the introduction of non-invasive maternal hemodynamic monitoring in clinical 
practice, it is imperative that methodology-specific reference ranges are established. 
Previous work investigating hemodynamics have been performed using 
thermodilution (14-16) and echocardiography (17-19). These methods have 
significant drawbacks, including the invasive nature and the requirement of specialist 
training and expertise, respectively.  
In the published literature, assessment of the performance of novel CO monitors 
against a reference method has been carried out using Bland–Altman analysis, 
which is the recommended method of statistical analysis when assessing two 
cardiac output devices (20). A mean percentage difference of <30% between two 
devices has been proposed as the level of clinical acceptability (21). Previous 
investigations focused on assessing the adequacy of interchangeable use of the two 
methods, or on the potential replacement of one method by another. However, these 
aims can be questioned in the present setting. USCOM-1A®, or any other similar 
device, will not replace thermodilution as the ‘gold standard’ method of CO 
estimation, and achieving a mean percentage difference of less than 30% remains 
difficult to attain. Indeed many comparison studies (5-8) evaluating USCOM against 
thermodilution have reported poor agreement (MPD >30%) when assessed against 
thermodilution or echocardiography. However, the limitations of the reference 
methods used in the studies should be taken into account, as these do not provide 
an error-free measurement of CO. Instead, we propose that USCOM-1A® will 
provide an alternative, non-invasive methodology enabling simple, bedside 
assessment of maternal hemodynamics. The benefits include excellent intra-
observer repeatability and inter-observer reproducibility (9, 13), and the potential for 
the measurements to be obtained by all levels of healthcare professional (22).  
The relationship between maternal hemodynamic variables and patient 
characteristics reported in this study are novel. CO decreases with advancing 
maternal age up until the age of 32, and SVR increases over a similar period. These 
findings are consistent with the inverse relationship observed between cardiac 
function and age, supporting the notion of increasing cardiovascular risk with 
advancing maternal age. Furthermore, the physiological consequence of a decrease 
in SVR in taller individuals will result in an increase in SV, as we report in this study.  
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Hypertensive disorders of pregnancy are associated with aberrations in maternal 
hemodynamics prior to the onset of clinical disease (23-26). Advancing maternal age 
is a recognised risk factor for hypertension in pregnancy (27). The findings of 
increased SVR and decreased CO observed in our cohort lend further support to the 
observed association between advancing age and risk of developing hypertension in 
pregnancy. Smoking is a known risk factor for cardiovascular disease, and is 
hazardous to fetal, child and maternal wellbeing (28-30). However, maternal smoking 
does have a protective effect on the development of pre-eclampsia, which has been 
demonstrated in epidemiological and molecular studies (31-33). Our reported finding 
of reduced SVR in smokers, provides further central hemodynamic evidence for the 
protective role of smoking with respect to hypertension in pregnancy.  
An unexpected finding was the lack of effect of maternal weight on SVR. Increasing 
maternal weight is also a known risk factor for hypertension in pregnancy. We 
postulate that the most likely explanation for the lack of effect of maternal weight on 
SVR, is that SVR is derived from mean arterial pressure and CO. Even though CO 
increases with weight, and should result in a decrease in SVR, mean arterial 
pressure also increases with weight. It would appear that these two cancel out, 
thereby explaining the lack of effect of maternal weight on SVR. Furthermore, the 
increase in BP seen with increasing maternal weight is due to an increase in CO, this 
is independent of SVR. Previous work from our group has shown no difference in 
SVR between morbidly obese pregnant women and normal BMI controls (submitted 
manuscript). Future studies to assess the structural and functional myocardial 
changes (using echocardiography) associated with increased maternal weight, and 
more specifically, weight gain in pregnancy are required to explore this.   
 
Study strengths and limitations   
This study includes a large cohort of uncomplicated low-risk singleton pregnancies. 
All patients who developed hypertension in pregnancy after being recruited to the 
study were excluded from the analysis, and therefore women who have altered 
haemodynamic function prior to the onset of clinical disease were not included in the 
study.  Furthermore, the statistical modelling has enabled the construction of 
reference ranges and the assessment of the potential relationship between maternal 
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characteristics and hemodynamics. Using a solitary hemodynamic assessment 
instead of multiple readings is a study limitation; one way to address this is o perform 
multiple, serial measurements in a subject over a defined time period – this is the 
aim of an ongoing research study.  We have previously reported excellent 
repeatability (ICC 0.969, 95% CI 0.953-0.980) and reproducibility (ICC 0.896, 95% 
CI 0.812-944) of USCOM® (9). One recognised limitation of the methodology used in 
this study is the use of an inherent normogram that estimates the left ventricular 
outflow tract (LVOT) diameter from the patients given height. The difference between 
the estimated and measured LVOT could be a source of potential bias. The bias 
resulting from this is a possible explanation for the difference in relationship 
observed between CO and maternal height below and above 1.6m. The authors 
recognise that a significant limitation of the methodology employed in this study is 
the poor agreement when assessed against invasive, reference methods in 
previously conducted comparison studies. A final study limitation is the lack of pre-
pregnancy and early pregnancy data, however this is the focus of ongoing research 
studies. 
 
Conclusion  
This study reports the SV, CO and SVR reference ranges, obtained using USCOM-
1A®, in uncomplicated singleton pregnancies. We also demonstrate the 
interrelationships between these hemodynamic parameters and maternal 
characteristics. The implications of the latter findings extend beyond pregnancy and 
are likely to influence the design and interpretation of future studies. 
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Table 1 Baseline characteristics and pregnancy outcomes of the study cohort. 
 
Maternal and pregnancy characteristics Value 
Maternal age in years, median (IQR) 32 (28-35) 
Ethnicity, n (%)  
   Caucasian 401 (64) 
   Afrocarribbean 97 (15) 
   Asian 103 (16) 
   Mixed / Other 22 (4) 
   Not stated 4 (1) 
Mode of Conception, n (%)  
   Spontaneous 611 (97) 
   Assisted 16 (3) 
Smoking status, n (%)  
   Non-smoker 588 (94) 
   Stopped in the first trimester 5 (1) 
   Smoker (≤5/day) 19 (3) 
   Smoker (≥6/day) 15 (2) 
Parity, n (%)  
   Nulliparous 325 (52) 
   Multiparous 302 (48) 
Maternal weight in kilograms, median (IQR) 74.0 (65.0-84.4) 
Maternal height in metres, median (IQR) 1.64 (1.60-1.69) 
Maternal BMI in kg/m2, median (IQR) 27.1 (24.3-31.2) 
Maternal mean arterial pressure in mmHg, median 
(IQR) 
85 (79-92) 
Mode of delivery, n (%)  
  Spontaneous vaginal delivery 330 (53) 
  Operative vaginal delivery 94 (15) 
  Caesarean Section  141 (22) 
  No delivery details 62 (10) 
Gestational age at delivery, n (%)  
   <37/40 (preterm) 32 (5) 
   >37/40 (term) 533 (85) 
   No delivery details 62 (10) 
Birthweight in grams, median (IQR)  3350 (3100-3680) 
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